COM:KARYOPHARM
Karyopharm Therapeutics Inc.
- Stock
Last Close
0.78
21/11 21:00
Market Cap
107.99M
Beta: -
Volume Today
278.50K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -33.95M - | -75.78M 123.22% | -118.18M 55.96% | -109.58M 7.28% | -128.98M 17.71% | -178.41M 38.32% | -199.59M 11.87% | -196.27M 1.66% | -124.09M 36.78% | -165.29M 33.20% | -143.10M 13.43% | |
depreciation and amortization | 144K - | 323K 124.31% | 634K 96.28% | 717K 13.09% | 713K 0.56% | 735K 3.09% | 974K 32.52% | 972K 0.21% | 789K 18.83% | 621K 21.29% | 530K 14.65% | |
deferred income tax | 1.78M - | 29K - | -1.38M 4,865.52% | 904K 165.41% | 1.45M 60.84% | -1.11M - | ||||||
stock based compensation | 3.79M - | 14.24M 276.22% | 17.06M 19.78% | 22.28M 30.64% | 20.41M 8.43% | 17.27M 15.34% | 15.29M 11.48% | 24.41M 59.62% | 29.78M 22.03% | 35.40M 18.86% | 21.71M 38.67% | |
change in working capital | -360K - | 9.71M 2,798.61% | 4.00M 58.85% | 987K 75.31% | 32.96M 3,239.61% | -169K 100.51% | -13.31M 7,774.56% | 1.36M 110.19% | -23.19M 1,810.10% | -19.99M 13.80% | 31.41M 257.16% | |
accounts receivables | -7.86M - | -5.02M 36.16% | -9.62M 91.59% | -5.08M 47.13% | 20.12M 495.83% | |||||||
inventory | -346K - | -2.63M 659.25% | -1.46M 44.35% | -118K 91.93% | 1.18M 1,100.85% | |||||||
accounts payables | 664K - | 4.50M 577.11% | -2.43M 153.96% | 945K 138.95% | 909K 3.81% | -1.38M 251.82% | -3.30M 139.20% | 3.46M 204.97% | -2.85M 182.16% | 1.17M 141.10% | 350K 70.09% | |
other working capital | -1.02M - | 5.22M 609.67% | 6.42M 23.09% | 42K 99.35% | 32.05M 76,216.67% | 1.21M 96.22% | -1.80M 248.55% | 5.54M 407.78% | -9.26M 267.31% | -15.96M 72.25% | 9.76M 161.16% | |
other non cash items | 88K - | 52K 40.91% | 685K 1,217.31% | 1.20M 75.04% | 1.19M 1.00% | 1.42M 19.63% | 7.19M 406.55% | 8.40M 16.78% | 8.13M 3.15% | -294K 103.61% | -2.16M 636.05% | |
net cash provided by operating activities | -30.29M - | -51.45M 69.85% | -94.03M 82.77% | -84.39M 10.25% | -73.72M 12.65% | -159.12M 115.85% | -190.82M 19.93% | -160.23M 16.03% | -107.12M 33.15% | -149.55M 39.62% | -92.72M 38.00% | |
investments in property plant and equipment | -57K - | -2.83M 4,871.93% | -1.42M 50.04% | -70K 95.06% | -62K 11.43% | -2.36M 3,711.29% | -206K 91.28% | -145K 29.61% | -5.71M 3,839.31% | -118K 97.93% | ||
acquisitions net | -78.66M - | 53.54M 168.07% | 5.50M 89.73% | 104.26M 1,795.56% | ||||||||
purchases of investments | -63.80M - | -305.19M 378.38% | -134.70M 55.86% | -98.37M 26.97% | -242.81M 146.82% | -178.49M 26.49% | -274.58M 53.83% | -45.23M 83.53% | -226.02M 399.73% | -159.15M 29.58% | ||
sales maturities of investments | 215.87M - | 159.37M 26.17% | 115.54M 27.50% | 137.51M 19.01% | 257.14M 87.00% | 221.04M 14.04% | 192.78M 12.78% | 121.88M 36.78% | 167.09M 37.10% | |||
other investing activites | -400K - | -82K 79.50% | 78.66M - | -53.54M 168.07% | -5.50M 89.73% | -104.26M 1,795.56% | ||||||
net cash used for investing activites | -57K - | -67.03M 117,498.25% | -90.82M 35.49% | 24.59M 127.08% | 17.11M 30.44% | -107.66M 729.32% | 78.45M 172.87% | -53.69M 168.43% | 141.84M 364.21% | -104.26M 173.50% | 7.94M 107.62% | |
debt repayment | -60M - | |||||||||||
common stock issued | 113.16M - | 112.84M 0.28% | 92.08M 18.39% | 50.57M 45.08% | 74.89M 48.07% | 145.71M 94.57% | 46.19M 68.30% | 161.78M 250.23% | 9.90M 93.88% | 189.76M 1,816.20% | 1.12M 99.41% | |
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 72.78M - | 284K 99.61% | 616K 116.90% | 591K 4.06% | 858K 45.18% | 170.40M 19,760.61% | 78.11M 54.16% | 10.31M 86.81% | 123.75M 1,100.59% | 3.98M 96.79% | ||
net cash used provided by financing activities | 185.93M - | 113.12M 39.16% | 92.70M 18.05% | 51.16M 44.81% | 75.74M 48.04% | 316.11M 317.34% | 124.31M 60.68% | 172.08M 38.44% | 73.65M 57.20% | 193.74M 163.06% | 1.12M 99.42% | |
effect of forex changes on cash | -8K - | -99K 1,137.50% | -63K 36.36% | 200K 417.46% | -78K 139% | 19K 124.36% | 268K 1,310.53% | -48K 117.91% | -488K 916.67% | -34K 93.03% | ||
net change in cash | 155.58M - | -5.37M 103.45% | -92.25M 1,619.50% | -8.70M 90.57% | 19.33M 322.36% | 49.25M 154.73% | 11.95M 75.73% | -41.57M 447.79% | 108.32M 360.59% | -60.56M 155.91% | -83.36M 37.65% | |
cash at beginning of period | 391K - | 155.97M 39,791.05% | 150.61M 3.44% | 58.36M 61.25% | 49.66M 14.90% | 69.49M 39.92% | 118.74M 70.88% | 130.69M 10.07% | 89.12M 31.81% | 197.44M 121.55% | 136.25M 30.99% | |
cash at end of period | 155.97M - | 150.61M 3.44% | 58.36M 61.25% | 49.66M 14.90% | 69.00M 38.93% | 118.74M 72.09% | 130.69M 10.07% | 89.12M 31.81% | 197.44M 121.55% | 136.88M 30.67% | 52.89M 61.36% | |
operating cash flow | -30.29M - | -51.45M 69.85% | -94.03M 82.77% | -84.39M 10.25% | -73.72M 12.65% | -159.12M 115.85% | -190.82M 19.93% | -160.23M 16.03% | -107.12M 33.15% | -149.55M 39.62% | -92.72M 38.00% | |
capital expenditure | -57K - | -2.83M 4,871.93% | -1.42M 50.04% | -70K 95.06% | -62K 11.43% | -2.36M 3,711.29% | -206K 91.28% | -145K 29.61% | -5.71M 3,839.31% | -118K 97.93% | ||
free cash flow | -30.35M - | -54.28M 78.87% | -95.44M 75.84% | -84.46M 11.51% | -73.78M 12.65% | -161.48M 118.87% | -191.03M 18.30% | -160.38M 16.04% | -112.83M 29.65% | -149.67M 32.66% | -92.72M 38.05% |
All numbers in (except ratios and percentages)